prostate cancer

Exelixis announces initiation of trial combining cabozantinib, abiraterone
Yahoo/Fly on the Wall
Mon, 03/5/12 - 11:12 am
Exelixis
cabozantinib
abiraterone
prostate cancer
Dendreon: Overall Survival Data For Provenge From 2012 GU Poster
Seeking Alpha
Fri, 02/17/12 - 01:15 pm
Dendreon
prostate cancer
Provenge
FDA panel votes against Xgeva for prostate cancer
Yahoo/AP
Wed, 02/8/12 - 03:12 pm
prostate cancer
Xgeva
FDA
Amgen
Can Amgen Convince Docs to Recommend Xgeva Approval?
Motley Fool
Wed, 02/8/12 - 09:32 am
Amgen
Xgeva
physicians
prostate cancer
FDA
FDA questions benefit of Amgen's bone drug for new use in prostate cancer patients
Yahoo/AP
Mon, 02/6/12 - 09:47 am
FDA
Amgen
prostate cancer
Xgeva
Amgen risk/reward attractive into Xgeva panel, says Deutsche Bank
Yahoo/Fly on the Wall
Fri, 02/3/12 - 10:00 am
Xgeva
Amgen
prostate cancer
advisory panels
J&J’s Zytiga for Prostate Cancer Too Expensive, U.K. Cost Agency Says
Bloomberg
Thu, 02/2/12 - 09:12 am
JNJ
Zytiga
prostate cancer
UK
Medivation says prostate cancer pill MDV3100 met goal in second clinical trial
Yahoo/AP
Wed, 02/1/12 - 12:21 pm
Medivation
prostate cancer
MDV3100
Dendreon And Provenge's True Median Life-Extension Benefit
Seeking Alpha
Wed, 02/1/12 - 11:36 am
prostate cancer
Provenge
Dendreon
Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
Seeking Alpha
Tue, 01/31/12 - 07:47 am
Dendreon
Provenge
prostate cancer
JNJ
Zytiga
Dendreon: Following Up On Market Mania
Seeking Alpha
Tue, 01/17/12 - 06:49 pm
Dendreon
prostate cancer
Provenge
Medivation Shrugs Off Alzheimer's Setback as Investors Eye New Prostate Cancer Data
TheStreet.com
Tue, 01/17/12 - 11:32 am
Medivation
prostate cancer
Alzheimer's disease
MDV3100
Amgen: Xgeva panel review scheduled for February
Yahoo/AP
Thu, 12/29/11 - 10:35 pm
Amgen
Xgeva
advisory panel
FDA
prostate cancer
Dendreon: Where Do Things Stand On Provenge Reimbursement?
Seeking Alpha
Wed, 12/21/11 - 12:56 pm
Provenge
prostate cancer
Dendreon
Dendreon 2011: Supply Constrained to Missed Guidance
Motley Fool
Fri, 12/16/11 - 11:31 am
Dendreon
guidance
Provenge
prostate cancer
Prostate Cancer Drugs Aren’t Tied to Heart Attacks, Study Says
Bloomberg Businessweek
Wed, 12/7/11 - 11:05 am
prostate cancer
AstraZeneca
Watson
Lupron
Abbott Laboratories
Vantas
Trelstar
Zoladex
Endo
Medivation Back to Neutral
Yahoo/Zacks
Sat, 11/26/11 - 10:22 am
Medivation
MDV3100
prostate cancer
Celgene Halts Prostate-Cancer Study for Top-Selling Revlimid
Bloomberg
Wed, 11/23/11 - 09:25 am
prostate cancer
Celgene
Revlimid
Time decay is key to Exelixis strategy
Yahoo/optionMONSTER
Tue, 11/22/11 - 11:58 am
Exelixis
cabozantinib
prostate cancer
Dendreon: Medicare will cover more Provenge costs
Yahoo/AP
Mon, 11/21/11 - 11:43 am
Dendreon
Medicare
Provenge
prostate cancer

Pages